-
Loading metrics
Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)
- Raja Dhar,
- John Kirkpatrick,
- Laura Gilbert,
- Arjun Khanna,
- Mahavir Madhavdas Modi,
- Rakesh K. Chawla,
- Sonia Dalal,
- Venkata Nagarjuna Maturu,
- Marcel Stern,
- Oliver T. Keppler
x
- Published: January 23, 2023
- https://doi.org/10.1371/journal.pone.0280745
- See the preprint